Despite securing two significant regulatory approvals from the U.S. Food and Drug Administration (FDA) in early March 2026, shares of...

In a significant strategic shift, China's coffee giant Luckin Coffee is moving beyond its discount roots. Through its major shareholder,...

The equity of German biotechnology firm BioNTech is navigating a period of significant volatility. As the company accelerates its strategic...

After hitting a provisional low last Tuesday, the KraneShares Electric Vehicles and Future Mobility Index is displaying initial signals of...

With the $83 billion acquisition of Warner Bros. Discovery officially off the table, Netflix is swiftly pivoting its strategy. Rather...

While Amazon aggressively pursues its global growth ambitions, a new category of physical threat has emerged. Recent drone strikes attributed...

Shares of New Fortress Energy are under pressure as the company confronts a $150 million cost overrun linked to its...

The Invesco Dynamic Pharmaceuticals ETF (ticker: PJP) has completed its latest quarterly rebalancing, entering the spring season with a refreshed...

The diagnostics firm T2 Biosystems has formally commenced a voluntary liquidation process, effectively winding down its business operations. This strategic...

A palpable sense of caution has settled over financial markets as the first week of March draws to a close....